Form4insider filings, from the source

SEC Form 4 · accession 0001232524-16-000216

Jazz Pharmaceuticals plc · JAZZ

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Matthew P. Young
Officer — EVP & CFO
Period of report
Feb 25, 2016
Accepted (ET)
Feb 29, 2016 · 8:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001232524

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF2Feb 25, 2016A9,000$0.00A36,960D
Ordinary SharesFeb 26, 2016F737$125.00D36,223D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Incentive Stock Option (right to buy)F4$123.36Feb 25, 2016A811A—Feb 24, 2026Ordinary Shares811811D
Non-Qualified Stock Option (right to buy)F4$123.36Feb 25, 2016A21,689A—Feb 24, 2026Ordinary Shares21,68921,689D

Explanation of responses